# An Open-Label Trial of Donepezil in Fragile X Syndrome

> **NCT00220584** · PHASE1 · COMPLETED · sponsor: **Stanford University** · enrollment: 10 (actual)

## Conditions studied

- Fragile X Syndrome

## Interventions

- **DRUG:** donepezil

## Key facts

- **NCT ID:** NCT00220584
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2012-12-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00220584

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00220584, "An Open-Label Trial of Donepezil in Fragile X Syndrome". Retrieved via AI Analytics 2026-08-11 from https://api.ai-analytics.org/clinical/NCT00220584. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*